Leiden Bio Science Park was proud to welcome Minister Fleur Agema for a visit organized by the Vereniging Innovatieve Geneesmiddelen. The tour highlighted how research, industry, and education come together in a unique ecosystem that powers life sciences innovation in the Netherlands.
The visit began at Johnson & Johnson Innovative Medicine, where the team showcased their lab-to-life model, from discovery to biologics production, emphasizing the global impact and local responsibility of Dutch biotech. Key challenges discussed included drug affordability, talent development, and patient access.
Led by Leiden Bio Science Park Director Esther Peters, the group cycled through the park to see how early research and industry collaborate closely. Stops included:
Leiden University, where LACDR, LIACS, and BioPartner support breakthroughs in pharmacology, AI, and quantum innovation
Leidse instrumentmakers School, highlighting the essential role of technical talent in medtech and instrumentation
Galapagos, where CAR T cell therapies are being developed at scale
Bristol Myers Squibb, where the upcoming CAR-T manufacturing site will serve patients across Europe
Our message to the Minister was clear: if the Netherlands wants to lead in life sciences, it must invest in strong, collaborative ecosystems like LBSP. We thank Minister Agema for her visit and welcome continued cooperation to shape the future of health.
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL...
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by...
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.